Start for free
Start for free
N

NeuroVentures

North America, Virginia, United States, Charlottesville

Description

NeuroVentures is a venture capital firm.

Investor Profile

NeuroVentures has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (44%)
  • Series A (22%)
  • Series D (11%)
  • Debt Financing (11%)
  • Series Unknown (11%)

Country Focus

  • United States (78%)
  • Canada (22%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Health Diagnostics
  • Medical Device
  • Neuroscience
  • Pharmaceutical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does NeuroVentures frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
H.I.G. Capital
H.I.G. Capital
North America, Florida, United States, Miami
Co-Investments: 2
Ventures West
Ventures West
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Bay City Capital
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 2
BDC Venture Capital
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 2
Technology Partners
Technology Partners
North America, California, United States, Palo Alto
Co-Investments: 2
Oxford Bioscience Partners
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 3
EQT Life Sciences
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Gray Ghost Ventures
Gray Ghost Ventures
North America, Georgia, United States, Atlanta
Co-Investments: 2
Delphi Ventures
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 2

Which angels does NeuroVentures often collaborate with?

LB
Lawrence Bloch
North America, Massachusetts, United States, Cambridge
Shared Deals: 2

What are some of recent deals done by NeuroVentures?

NeurAxon

Toronto, Ontario, Canada

NeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.

BiotechnologyNeuroscienceTherapeutics
Debt FinancingSep 30, 2010
Amount Raised: $14,000,000
BrainCells

San Diego, California, United States

BrainCells is a biotechnology startup focused on drugs intended to stimulate the growth of new neurons.

BiotechnologyHealth CareMedical Device
Series BMar 1, 2008
Amount Raised: $30,000,000
NeurAxon

Toronto, Ontario, Canada

NeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.

BiotechnologyNeuroscienceTherapeutics
Series BAug 20, 2007
Amount Raised: $32,000,000
Acumen Pharmaceuticals

Carmel, Indiana, United States

Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

BiotechnologyHealth DiagnosticsTherapeutics
Series UnknownAug 17, 2006
Amount Raised: $1,500,000
BrainCells

San Diego, California, United States

BrainCells is a biotechnology startup focused on drugs intended to stimulate the growth of new neurons.

BiotechnologyHealth CareMedical Device
Series AJul 15, 2005
Amount Raised: $17,700,000
Kadmus Pharmaceuticals

San Mateo, California, United States

Kadmus Pharmaceuticals, Inc., a biopharmaceutical company, commercially exploits endocannabinoid pathways to develop therapeutics.

BiotechnologyHealth CarePharmaceutical
Series AFeb 10, 2004
Amount Raised: $15,300,000
Saegis Pharmaceuticals

Half Moon Bay, California, United States

Saegis Pharmaceuticals is focused on the development of medicines that address behavioral disorders.

BiopharmaBiotechnologyHealth CareMedical
Series BNov 17, 2003
Amount Raised: $30,000,000
Scion Pharmaceuticals

Boston, Massachusetts, United States

Scion Pharmaceuticals is a Biotechnology company.

BiotechnologyMedical
Series BJul 15, 2002
Amount Raised: $17,500,000
Proxima Therapeutics

Alpharetta, Georgia, United States

Proxima Therapeutics develops radiation delivery systems for the treatment of solid cancerous tumors.

Health CareHealth DiagnosticsMedical
Series DFeb 2, 2001
Amount Raised: $17,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator